Table II. Characteristics of the validation population.
Validation population | n |
---|---|
Mesothelioma | 37 |
Epithelioid | 30 |
Biphasic | 5 |
Sarcomatoid | 2 |
Metastatic carcinomas | 25 |
Lung | 20 |
Breast | 4 |
Kidney | 1 |
Benign diseases | 16 |
BAP | 9 |
PPP | 3 |
TBC | 2 |
CHF | 2 |
BAP, benign asbestos pleuritis; PPP, parapneumonic pleurisy; TBC, tuberculosis; CHF, congestive heart failure. All pleural effusions were collected at the Chest Diseases Department of Eskisehir Osmangazi University in Eskisehir, Turkey.